Boundless Bio, Inc. (BOLD)
NASDAQ: BOLD · Real-Time Price · USD
1.440
-0.010 (-0.69%)
Jun 1, 2026, 4:00 PM EDT - Market closed
Boundless Bio Market Cap
Boundless Bio has a market cap or net worth of $32.28 million as of June 2, 2026. Its market cap has decreased by -3.21% in one year.
Market Cap
32.28M
Enterprise Value
-12.28M
1-Year Change
-3.21%
Ranking
Category
Stock Price
$1.44
Market Cap Chart
Since the IPO on March 28, 2024, Boundless Bio's market cap has decreased from $355.83M to $32.28M, a decrease of -90.93%. That is a compound annual growth rate of -66.91%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 29, 2026 | 32.51M | 21.01% |
| Dec 31, 2025 | 26.86M | -58.46% |
| Dec 31, 2024 | 64.67M | -81.83% |
| Mar 28, 2024 | 355.83M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| ABVC BioPharma | 35.63M |
| Aligos Therapeutics | 35.27M |
| Lite Strategy | 34.37M |
| Daré Bioscience | 33.40M |
| Evaxion | 33.36M |
| Tevogen Bio Holdings | 33.12M |
| Polyrizon | 32.14M |
| Tvardi Therapeutics | 31.71M |